2,598
Participants
Start Date
May 31, 2004
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
erythropoietin and cell saver
weekly 40.000 IU s.c. for 4 weeks pre-operatively; use of cell saver includes intra- and post-operative drainage and reinfusion
erythropoietin
weekly 40.000 IU s.c. for 4 weeks pre-operatively
OrthoPAT
for intra- and post-operative re-infusion of autologous wound blood
Post-operative drain device
For post-operative re-infusion of unwashed wound blood
Erythropoietin and OrthoPAT
weekly 40.000 IU s.c. for 4 weeks pre-operatively
Erythropoietin and drain device
weekly 40.000 IE s.c.for 4 weeks pre-operatively; drain use in post-operative period
OrthoPAT
For intra- and post-operative reinfusion of autologous blood
Slotervaart Hospital, Amsterdam
Albert Schweitzer Hospital, Dordrecht
Groene Hart Hospital, Gouda
LUMC, Leiden
Collaborators (1)
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Roche BV Netherlands
UNKNOWN
Haemonetics Corporation
INDUSTRY
Sanquin Research & Blood Bank Divisions
OTHER